Byondis

19/08/2023

A change of focus can boost creativity!

At Byondis our brightest minds of highly educated scientists and technicians who are to for patients also have a keen eye for photography. Today on we are delighted to show some of their work. Creativity is contagious and inspirational, encourages teamwork and collaboration.

16/08/2023

We believe in the benefits of sharing knowledge for the long-term positive results of the community. Byondis therefore supports introducing children to science and technology and support new initiatives for university students who are encouraged to grow an interest in science, especially around research on medicines.
Want to know more about what we do? Check out our newsletter ‘Beyond Science’!

📸 Photography IMC Weekendschool – © Joni Reiche

03/08/2023

Onze Byondis zwemmers zijn ook dit jaar weer van de partij op 10 september a.s. bij Swim to Fight Cancer Nijmegen om zo een bijdrage te kunnen leveren aan belangrijk onderzoek tegen kanker. 🏊‍♂️ 💜 🧡 🎗

01/08/2023

Vandaag is het Wereld Longkanker Dag, elk jaar gehouden op 1 augustus om meer bewustzijn voor (de gevolgen van) longkanker te creeren het belang van meer longkanker onderzoek financiering te vergroten. Deze dag herdenkt, viert en ondersteunt degenen die getroffen zijn door longkanker.

Longkanker blijft wereldwijd een van de meest voorkomende kankers en eist jaarlijks meer levens dan borst-, darm- en prostaatkanker samen. Geschat wordt dat longkanker verantwoordelijk is voor bijna een op de vijf sterfgevallen door kanker wereldwijd.

Bij Byondis werken we elke dag aan het vinden van nieuwe behandelingsopties met het doel om een betere behandeling voor patiënten te kunnen realiseren.

21/07/2023

Felicitaties en een pluim voor alle deelnemers aan de 4Daagse die deze week dit grootste wandelevenement ter wereld hebben afgesloten. Het felbegeerde 4Daagsekruisje is zeer welverdiend en een teken van jullie toewijding en veerkracht. Een enorm applaus voor alle wandelaars waaronder onze Byondis collega's en hun vrienden die zichzelf hebben uitgedaagd tijdens deze 105e editie en zo de finishlijn hebben behaald!!

18/07/2023

Het is begonnen! De Nijmeegse Vierdaagse! Samen met NXP Semiconductors, Gemeente Nijmegen, Radboudumc, Radboud University en Novio Tech Campus ondersteunt Byondis dit jaar de Health & High-Tech pitstops waar de Vierdaagse deelnemers van deze respectievelijke organisaties terecht kunnen voor een rustmoment, een hapje en drankje en de nodige aanmoedigingen. Voor alle 4Daagse wandelaars, vrijwilligers en supporters: heel veel plezier en blijf gezond!

14/07/2023

Welkom bij de Health & High Tech Lounge op het Mariënburgplein!

Morgen gaan de Vierdaagsefeesten van start in Byondis' thuisbasis Nijmegen. Tijdens deze mooiste 7 dagen van het jaar zullen 1,5 miljoen bezoekers genieten van de grootste festiviteiten van het land. De vieringen zijn een opmaat naar het wereldberoemde 4Daagse wandelevenement dat a.s. dinsdag van start gaat.

Samen met NXP Semiconductors, Gemeente Nijmegen, Radboudumc, Radboud University en Novio Tech Campus ondersteunt Byondis de Health & High-Tech 4Day Marches Lounge op het Mariënburgplein. Dit ontmoetingspunt in het centrum van de stad is een plek om samen te komen en bij te praten met elkaar en vertegenwoordigers van belangrijke Health & High Tech organisaties in Nijmegen.

We kijken er naar uit om je te verwelkomen in de Health & High Tech Lounge!

12/07/2023

Byondis CEO and Board member of The Economic Board Regio Arnhem Nijmegen, Marco Timmers, in conversation with John van Sambeek, Civic Entrepreneur Health & Hightech of The Economic Board Regio Arnhem Nijmegen about the strength of the region, searching and finding talent and the importance of targeted collaboration.

Het terrein aan de Microweg in Nijmegen is een campus in ontwikkeling, waar met meer dan 400 medewerkers gewerkt wordt aan het realiseren van de hoop van patiënten op een betere kwaliteit van leven. Hier is Byondis gevestigd en legt men zich volledig toe op de ontwikkeling van veilige en effectieve...

12/07/2023

We have a winner! This year's recipient of the Byondis Molecular Sciences Scholarship is Devon Blom! Congratulations Devon! Wishing you lots of success with your studies at the Radboud University, and we trust our scholarship contribution will provide you with additional insights and support.

https://www.byondis.com/who-we-are/sustainability/scholarship

06/07/2023

Summer is a time to relax and re-energize. ☀️ Enjoying a very well-deserved time off with friends and family and recharging our batteries. Keeping our balance is how we at Byondis can continue to focus on our ultimate goal to for patients. Work hard, have fun, make a difference!

30/06/2023

Never want to miss out on anything we do at Byondis? Through our social pages you can be updated on our newest job openings, latest press releases, the development of our company and our discoveries!

We value everyone who follows us on social and interacts with our posts through a like or a comment. Thank you so much! 💜🧡

21/06/2023

Our Bioanalysis & Protein Interaction department is looking for a Research Analyst with an interest in the immuno-oncology field! This department is responsible for (bio)analytical support in all stages of our biopharmaceutical pipeline. As a Research Analyst…

🟣 You will work together with other analysts and researchers to develop, qualify and execute immunoassays.
🟣 You take responsibility for the experimental lab work, and generate, process and report data of ‘fit-for-purpose’ quality and integrity.

Ready to take on this opportunity? Join Byondis and create the future you want, today! More information: https://byondis.easycruit.com/vacancy/3188171/190513

20/06/2023

Caring for people is fundamental to our company. Improving and innovating our health and safety processes, preventing incidents and making sure all our employees return home happy and safely everyday are all things we feel responsible for. Our people make hope real.

16/06/2023

Coming Sunday we celebrate Father's Day in the Netherlands.

We are grateful to have impressive father role models as colleagues and as our friends. Some of us may have lost their fathers and find time to reminisce, or have someone else to look up to as a father figure. We celebrate all our fathers, to-be fathers, father figures, and everyone else who fulfills that role.

06/06/2023

We are looking for a highly-motivated Research Technician to join our growing team!

Are you interested in performing cell-based assays for immuno-oncology research and looking for a new challenge? Our In Vitro Pharmacology department is part of our research division and works on the early stage development of our biopharmaceutical pipeline.

As our new Research Technician you will:
🟣 Be primarily responsible for the ex*****on and the experimental design of in vitro studies for our novel immunotherapies development.
🟣 Develop, optimize and run immune cell-based assays to profile and study the mechanism of our monoclonal antibodies, ADCs or small molecules.
🟣 Work closely together in a team of principal investigators, researchers and technicians.

Are you ready to join Byondis and create the future you want?

Apply at: https://byondis.easycruit.com/vacancy/3181107/190513

02/06/2023

This Sunday, June 4th, is Cancer Survivors Day. This is an important day, because we need to celebrate these survivors, as well as the scientific strides responsible for their ability to thrive throughout the years.

On Cancer Survivors Day, people around the world unite to recognize cancer survivors, raise awareness of the ongoing challenges cancer survivors face, and – most importantly – celebrate life.

01/06/2023

At Byondis our strength lies in differences, not in similarities.. Coming from different backgrounds, countries, cultures, experiences and beliefs cultures and beliefs, we celebrate our diversity, while cherishing a culture of belonging.❤️🧡💛💚💙💜

25/05/2023

Did you know that 40% of cancer cases in Europe are preventable?
If we don't act now, cancer cases are set to increase over 24% by 2035, making it the leading cause of death in the EU.

We join the European Week Against Cancer and the fight against cancer in Europe.

24/05/2023

Do you want to help Byondis transform their IT Infrastructure and improve performance by using the latest technologies? Our Information Technology department is looking for an Infrastructure Engineer.

Together with a team of engineers, you will be responsible for the security, design, installation and management of our IT infrastructure and enhancement projects for offices, laboratories and manufacturing.

Apply for this job at: https://byondis.easycruit.com/vacancy/3167317/190513

23/05/2023

This week is the last opportunity to send in applications for our Molecular Sciences Scholarship! The 10th scholarship winner will be granted regular company visits, guided tours, support from a Byondis mentor and more!

Apply for the scholarship at https://www.ru.nl/en/education/scholarships/byondis-molecular-sciences-scholarship

19/05/2023

Did you know that there are currently more than 451,000 clinical trials underway in 221 countries. Tomorrow, May 20, is , a day that recognizes clinical researchers in industry, academia and the public sector, as well as the patients who participate in trials. Learn more in a blog from Byondis’ Vice President, Corporate Communications, Corina Ramers-Verhoeven. https://www.byondis.com/who-we-are/blogs/2023-05-19

17/05/2023

Integrity, authenticity, entrepreneurship, quality and trust. These core values are the values that we feel are so fundamental that we would hold them, regardless of whether or not they are rewarded.

We are as proud of our scientific expertise as we are of the people who make up our company.

Find out more: https://www.byondis.com/who-we-are/core-values

12/05/2023

This Sunday it’s Mother’s Day in our country!

An opportunity to show how grateful we are to have powerful mothers as friends, colleagues, and partners. Lets also reflect and think of all who have lost their mother, lost a child or wished to become a mother themselves.

To all of you: You are wonderful, extraordinary, and incredible.

10/05/2023

Today on World Facility Management Day, we recognize and celebrate the contributions of our Byondis colleagues working in Facility Management. They give true meaning to this year's theme of the day: “Making a real difference.” A well-deserved thanks for these behind-the-scenes heroes for keeping us happy and alert and our campus healthy, safe and productive.

05/05/2023

Vandaag vieren we de vrijheid. Vrij zijn betekent dat we de wereld kunnen veranderen en elke dag positieve bijdragen kunnen leveren.
We wensen iedereen een mooie Bevrijdingsdag! 🇳🇱

04/05/2023

Vanavond herdenken wij alle slachtoffers van oorlogen met twee minuten stilte.

Op 4 mei herdenkt Nederland alle Nederlandse slachtoffers tijdens en vanaf de Tweede Wereldoorlog. Dit zijn militairen en burgers die stierven in oorlogssituaties en bij vredesoperaties.

Onze gedachten zijn bij alle mensen die waar dan ook ter wereld slachtoffer zijn van gewelddadige conflicten.

28/04/2023

We value our employees above all and believe they each have something unique and valuable to contribute to our goal to .

Today, at World Day for Safety and Health at Work we pay special attention to a safe and healthy working environment on our Byondis Campus. Byondis’ commitments with respect to environment, health, and safety (EHS) aim to ensure that our activities are performed in a manner that reduces negative environmental impact and is safe for our employees and other stakeholders, including customers, suppliers, and neighbors.

27/04/2023

We wensen iedereen veel plezier op Koningsdag vandaag! 🧡👑

26/04/2023

With this year’s theme of World Intellectual Property Day “Women and IP: Accelerating innovation and creativity” we celebrate all women in our organization who contribute to our innovative, creative and groundbreaking discoveries! The women (and men!) at Byondis are shaping the world through their imagination, ingenuity and hard work.

15/07/2020

At Byondis, we aim to outsmart relentless cancers, such as advanced endometrial (uterine) cancer. So we’re pleased to announce the start of a Phase II study of our investigational antibody-drug conjugate (ADC) [vic-]trastuzumab duocarmazine (SYD985.) https://www.byondis.com/who-we-are/press-releases/2020-07-15